CORCEPT THERAPEUTICS I
54.30
07-十一月-24 14:59:58
15 分钟延时
股票
+0.07
+0.13%
今日范围
53.65 - 55.24
ISIN
N/A
来源
NASDAQ
-
24 6月 2024 15:15:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
06 6月 2024 08:45:18 条件 NetDania Notify
-
NetDania - New 12 months High: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
05 6月 2024 12:50:40 条件 NetDania Notify
-
03 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
28 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
01 5月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Completes Enrollment in Phase 4 CATALYST Trial
29 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
24 4月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
22 4月 2024 08:59:41 条件 NetDania Notify
-
22 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
15 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
08 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
15 2月 2024 15:07:00 条件 Nasdaq GlobeNewswire
-
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
15 2月 2024 15:02:00 条件 Nasdaq GlobeNewswire
-
08 2月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Appoints Roberto Vieira as President, Oncology
29 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
08 1月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Court Finds Corcept Therapeutics’ Patents Not Infringed
02 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
01 11月 2023 15:05:00 条件 Nasdaq GlobeNewswire